SLC5A2 and chronic kidney disease: Convincing in vitro and in vivo data suggest ketone bodies inhibit the mTOR1 pathway and their production is, in part, responsible for the SGLT2‐induced nephroprotection in both high fat diet and surgical nephrectomy‐induced CKD in mice (Tomita et al., 2020).